Couch in Crisis

Judith Joseph, MD, MBA, shares her journey of balancing clinical work with social media mental health advocacy.

The CDC suggests that disrupted access to ADHD medications may increase risk of overdose and injury.

The Psychiatric Times Editor-in-Chief discusses the clinical uses and casual prescribing of ketamine for the treatment of psychiatric disorders.

A psychiatrist reflects and laments on the state of the country.

Carmen Kosicek, MSN, PMHNP-BC, and team share their excitement over potential new options pending the FDA's Advisory Committee meeting.

A psychiatrist reflects on the importance of time... and living in the moment.

From personality disorders and common comorbidities to the effects of abortion bans on mental health, here are highlights from the week in Psychiatric Times.

The experts weighed in on a wide variety of psychiatric issues for the February 2024 issue of Psychiatric Times.

A medical student's award-winning piece on her battles with an eating disorder.

Here are highlights from some of the year’s top features in Psychiatric Times from throughout 2023.

With hate speech prevalent on college campuses and elsewhere, a psychiatrist ponders the psychiatric perspective and importance of therapeutic speech.

As the trauma and grief of the Mideast war hit his own community , a psychiatrist helps promote healing.

What have we learned—and what do we need to know—about the mental health implications of organizational and governmental dictatorships?

Can the foundations of psychotherapy provide insight into today's conflict?

A psychiatrist reflects on how much we all have in common and the need for healing...

Can psychiatry and psychiatrists come together for a joint healing statement?

From deep brain stimulation for treatment-resistant schizophrenia to a look at the potential trajectory of artificial intelligence in psychiatry and medicine, here are highlights from the week in Psychiatric Times.

“Israel is experiencing national trauma—one that is believed to signal long-lasting implications for the future.”

From long-acting injectable antipsychotics for managing schizophrenia to mental health responses to the recent conflict in Israel, here are highlights from the week in Psychiatric Times.

What is the psychiatric impact of the current war in Gaza?

The experts weighed in on a wide variety of psychiatric issues for the September 2023 issue of Psychiatric Times.

From violence risk assessment in emergency departments to connections between bipolar disorder and substance use disorders, here are highlights from the week in Psychiatric Times.

How can we ensure that diversity, equity, inclusion, and access are truly achieved in clinical trials industry-wide?

From new research on psilocybin as a treatment for MDD to new FDA approvals for ADHD and BED, here are highlights from the week in Psychiatric Times.

In this insightful interview, experts discuss the journey toward a more humanistic approach in psychiatry, the challenges of integrating biological and psychosocial aspects, and the need for comprehensive training for future psychiatrists.

How can clinicians recognize and acknowledge the injustices often experienced by COVID long-haulers?

As we commemorate the landmark March on Washington, parallels are drawn between Dr Martin Luther King Jr's dreams of equality and the goals of social psychiatry, highlighting the need to address social determinants of mental health.

From informed consent in treatment with psychedelics to an anti-fentanyl antibody that may reverse the signs of carfentanil overdose, here are highlights from the week in Psychiatric Times.

"By developing strategies that reduce both stigma and normalization, we can create a more supportive environment for those at risk and improve suicide prevention efforts."

The experts weighed in on a wide variety of psychiatric issues for the July 2023 issue of Psychiatric Times.